A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)

clinical trial

A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00529373

P6099clinical trial phasephase III clinical trialQ42824827
P582end time2012-11-01
P1050medical conditionosteoporosisQ165328
P2899minimum age65
P1132number of participants16713
P4844research intervention(5R)-24,25-Dihydroxyvitamin DQ27161510
calcium oxalateQ412399
P580start time2007-09-01
P8363study typeinterventional studyQ78089383
P1476titleA Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium

Search more.